Literature DB >> 8195723

Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome.

S Kovats1, S Drover, W H Marshall, D Freed, P E Whiteley, G T Nepom, J S Blum.   

Abstract

The human immunodeficiency, type II bare lymphocyte syndrome (BLS), has been attributed to a defect in the transcription of class II histocompatibility genes. Immunocompetence, as assessed by functional exogenous antigen presentation, was not restored in immortalized B cells, derived from a BLS patient, after transfection with HLA-DR class II structural genes. Incubation of protein antigens, as well as infectious virus, with DR-transfected BLS cells failed to induce activation of antigen-specific helper T lymphocytes. Peptide antigens were presented by class II molecules displayed on BLS cells, although the conformation of these class II proteins was altered as indicated by epitope mapping. This defect in antigen presentation was independent of the specific class II DR allele transfected into BLS cells. Genetic complementation analysis has been used with BLS cells to demonstrate that the defect in class II gene transcription is linked to the absence of a trans-acting factor. Similarly, functional class II dimers were restored after in vitro fusion of cells derived from two distinct BLS complementation groups, implying that specific transcriptional control elements are shared by a gene critical for antigen presentation and genes encoding HLA class II antigens. Thus, two important functionally linked pathways of class II molecules, structural gene expression and antigen presentation, share a common regulatory pathway defective in BLS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195723      PMCID: PMC2191518          DOI: 10.1084/jem.179.6.2017

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.

Authors:  J M Riberdy; P Cresswell
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

2.  Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.

Authors:  J I Krieger; R W Karr; H M Grey; W Y Yu; D O'Sullivan; L Batovsky; Z L Zheng; S M Colón; F C Gaeta; J Sidney
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

3.  Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients.

Authors:  C R Hume; L A Shookster; N Collins; R O'Reilly; J S Lee
Journal:  Hum Immunol       Date:  1989-05       Impact factor: 2.850

4.  Regulation of the class II-associated invariant chain gene in normal and mutant B lymphocytes.

Authors:  C Doyle; P J Ford; P D Ponath; T Spies; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Genetic complexity of regulatory mutants defective for HLA class II gene expression.

Authors:  C Seidl; C Saraiya; Z Osterweil; Y P Fu; J S Lee
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

8.  A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.

Authors:  B Lisowska-Grospierre; D J Charron; C de Préval; A Durandy; C Griscelli; B Mach
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex.

Authors:  E Mellins; S Kempin; L Smith; T Monji; D Pious
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3.

Authors:  J P Johnson; T Meo; G Riethmüller; D J Schendel; R Wank
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Impaired regulation of HLA-DR expression in human immunodeficiency virus-infected monocytes.

Authors:  Ling Shao; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.

Authors:  R M Hershberg; P E Framson; D H Cho; L Y Lee; S Kovats; J Beitz; J S Blum; G T Nepom
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

4.  Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.

Authors:  P A Muraro; M Vergelli; M Kalbus; D E Banks; J W Nagle; L R Tranquill; G T Nepom; W E Biddison; H F McFarland; R Martin
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

5.  Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.

Authors:  S Kovats; G T Nepom; M Coleman; B Nepom; W W Kwok; J S Blum
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

6.  DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype.

Authors:  Ivana Durinovic-Belló; Silke Rosinger; Jennifer A Olson; Mauro Congia; Regina C Ahmad; Mathias Rickert; Johannes Hampl; Hubert Kalbacher; Jan W Drijfhout; Elizabeth D Mellins; Sascha Al Dahouk; Thomas Kamradt; Markus J Maeurer; Carol Nhan; Bart O Roep; Bernhard O Boehm; Constantin Polychronakos; Gerald T Nepom; Wolfram Karges; Hugh O McDevitt; Grete Sønderstrup
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

7.  Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6p.

Authors:  S P Fling; J Rak; K A Muczynski; B Arp; D Pious
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

8.  Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.

Authors:  J Douhan; I Hauber; M M Eibl; L H Glimcher
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.